Ganoderma lucidum Prevents Cisplatin-Induced Nephrotoxicity through Inhibition of Epidermal Growth Factor Receptor Signaling and Autophagy-Mediated Apoptosis
Background. Cisplatin (cis-diaminedichloroplatinum, CDDP) is a broad-spectrum antineoplastic agent. However, CDDP has been blamed for its nephrotoxicity, which is the main dose-limiting adverse effect. Ganoderma lucidum (GL), a medicinal mushroom, has antioxidant and inflammatory activities. Therefo...
Main Authors: | Yasmen F. Mahran, Hanan M. Hassan |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Oxidative Medicine and Cellular Longevity |
Online Access: | http://dx.doi.org/10.1155/2020/4932587 |
Similar Items
-
Epidermal growth factor receptor inhibition with erlotinib partially prevents cisplatin-induced nephrotoxicity in rats.
by: Yukihiro Wada, et al.
Published: (2014-01-01) -
Prevention of cisplatin nephrotoxicity
by: Hayati Fatemeh, et al.
Published: (2016-01-01) -
Suppression of Cisplatin-Induced Hepatic Injury in Rats Through Alarmin High-Mobility Group Box-1 Pathway by Ganoderma lucidum: Theoretical and Experimental Study
by: Hassan HM, et al.
Published: (2020-06-01) -
Reappraisal of Ganoderma lucidum :
by: Yau Wen Huang, et al.
Published: (2009) -
A Ribonuclease Isolated from Wild Ganoderma Lucidum Suppressed Autophagy and Triggered Apoptosis in Colorectal Cancer Cells
by: Xiuli Dan, et al.
Published: (2016-07-01)